Cancer cells can evade immune destruction by enhancing expression of immune checkpoints, including programmed cell death protein-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) [15]. Here, CTLA4 is linked to cancer.